◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Fuso Pharmaceutical Industries,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 12, 2025Q4 2024Nov 12, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income 2.4B 1.1B -- -- -- --
Operating Margin % 113.6% 100.1% -- -- -- --
+Ordinary Income 2.1B 1.1B -- -- -- --
Revenue Growth % 95.2% -- -- -- -- --
Line ItemQ4 2025Nov 12, 2025Q4 2024Nov 12, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 48.3B 44.9B -- -- -- --
Total Assets 81.7B 75.8B 74.7B 71.5B 69.7B 72.2B
Current Liabilities 44.1B 29.6B -- -- -- --
Total Liabilities 48.7B 39.1B 38.7B 36.7B 35.9B 38.6B
Total Equity 33.0B 36.7B 36.0B 34.8B 33.7B 33.5B
Equity Ratio -- -- 0.48 0.49 0.48 0.47
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...